| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/GYNO.2000.6070 |
| P698 | PubMed publication ID | 11161859 |
| P2093 | author name string | Kacinski BM | |
| Flick MB | |||
| Chambers JT | |||
| Chambers SK | |||
| Toy EP | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian carcinoma | Q18556145 |
| macrophage | Q184204 | ||
| P304 | page(s) | 194-200 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma | |
| P478 | volume | 80 |
| Q37346072 | Biomarker discovery in ovarian cancer. |
| Q37516304 | Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma |
| Q39986346 | CSF1R copy number changes, point mutations, and RNA and protein overexpression in renal cell carcinomas |
| Q38983252 | Cell-based biological evaluation of a new bisamide FMS kinase inhibitor possessing pyrrolo[3,2-c]pyridine scaffold |
| Q40751685 | Clone and expression of mutant M-CSF and its receptor from human leukemic cell line J6-1. |
| Q33403766 | Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor |
| Q35992191 | FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis |
| Q37995562 | FMS Kinase Inhibitors: Current Status and Future Prospects. |
| Q41885351 | Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate |
| Q34135327 | Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence |
| Q35584172 | High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection |
| Q38112353 | IL-34 and CSF-1: similarities and differences |
| Q34115782 | Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. |
| Q30842944 | Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data |
| Q39155601 | Macrophage density and macrophage colony-stimulating factor expression predict the postoperative prognosis in patients with intrahepatic cholangiocarcinoma |
| Q26999068 | Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review |
| Q26747129 | Mouse models for radiation-induced cancers |
| Q36219744 | Phosphoproteomics for oncology discovery and treatment |
| Q28748716 | Profiling Y561-dependent and -independent substrates of CSF-1R in epithelial cells |
| Q34024957 | Radiation-induced myeloid leukemia in murine models |
| Q33694369 | Role of CSF-1 in progression of epithelial ovarian cancer |
| Q39934697 | Role of microRNAs in drug-resistant ovarian cancer cells |
| Q44720331 | SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model |
| Q37021452 | The glucocorticoid receptor signalling in breast cancer |
| Q37118142 | The impact of T-cell immunity on ovarian cancer outcomes |
| Q37385514 | The mammalian ovary from genesis to revelation |
| Q36982940 | The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer |
| Q38027966 | The role of microRNA in the response to cisplatin treatment |
| Q35582297 | Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. |
| Q38948066 | Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion |
| Q93022424 | miR-1254 inhibits progression of glioma in vivo and in vitro by targeting CSF-1 |
Search more.